-
La Jolla Pharma Receives Orphan Designation for Malaria Treatment
contractpharma
July 24, 2019
LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection.
-
Need better collaboration to eliminate Malaria in Asia
biospectrumasia
June 18, 2019
Since 2010, cases have dropped by 60 per cent.
-
Triclosan may help fight drug-resistant malaria
europeanpharmaceuticalreview
April 30, 2019
Triclosan may help fight drug-resistant malaria.
-
Asian malaria endgame under threat
biospectrumasia
April 29, 2019
Asian experts fear that the last mile in malaria elimination in the region is threatened by increasing resistance to antimalarials and insecticides – new tools will be needed to defeat the disease
-
Primaquine-methylene blue combination blocks malaria transmission
europeanpharmaceuticalreview
April 29, 2019
An international team of researchers has shown that two different compounds-one, an older malaria drug, the other a common laboratory dye with known antimalarial properties-can safely and...
-
Fosmidomycin-piperaquine combination provides promising malaria treatment
europeanpharmaceuticalreview
April 29, 2019
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication…
-
Primaquine-methylene blue combination blocks malaria transmission
europeanpharmaceuticalreview
April 29, 2019
Researchers have shown that two different compounds can safely and effectively be added to treatment regimens to block the transmission of the most common form of malaria…
-
GSK commits $100m to increase vaccine manufacturing in US
pharmaceutical-technology
April 28, 2019
GlaxoSmithKline (GSK) has announced plans to invest $100m to support long-term vaccine manufacturing capabilities at its facility in Hamilton, Montana, US.
-
$4.3m donated to PATH’s Visualise No Malaria scheme
pharmaceutical-technology
April 26, 2019
At a World Malaria Day event in Paris, four technology companies have announced they will contribute $4.3m in technical support to healthcare non-profit PATH’s Visualise No Malaria project.
-
FDA awards breakthrough status to La Jolla’s malaria therapy
europeanpharmaceuticalreview
April 26, 2019
FDA awards breakthrough status to La Jolla’s malaria therapy.
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight June 2024: Globalization on the Go
